Correlation Between Enanta Pharmaceuticals and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Collegium Pharmaceutical, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Collegium Pharmaceutical.
Diversification Opportunities for Enanta Pharmaceuticals and Collegium Pharmaceutical
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enanta and Collegium is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Collegium Pharmaceutical
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Collegium Pharmaceutical. In addition to that, Enanta Pharmaceuticals is 1.01 times more volatile than Collegium Pharmaceutical. It trades about -0.5 of its total potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.21 per unit of volatility. If you would invest 3,414 in Collegium Pharmaceutical on September 1, 2024 and sell it today you would lose (364.00) from holding Collegium Pharmaceutical or give up 10.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Enanta Pharmaceuticals vs. Collegium Pharmaceutical
Performance |
Timeline |
Enanta Pharmaceuticals |
Collegium Pharmaceutical |
Enanta Pharmaceuticals and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enanta Pharmaceuticals and Collegium Pharmaceutical
The main advantage of trading using opposite Enanta Pharmaceuticals and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Money Managers Screen money managers from public funds and ETFs managed around the world |